Studies on the effect of tumor type and route of administration on the antitumor activity of the amino acid mimosine (NSC-69188).
D000284:Administration, Oral; D000409:Alanine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000468:Alkalies; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D002279:Carcinoma 256, Walker / Q000188:drug therapy; D007275:Injections, Intravenous; D007939:Leukemia L1210 / Q000188:drug therapy; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011728:Pyridones / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D013997:Time Factors; D014184:Transplantation, Homologous; D014867:Water
D000468:Alkalies; D000970:Antineoplastic Agents; D011728:Pyridones; D014867:Water; D000409:Alanine